Investigation and management of hypertriglyceridaemia

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Syndrome

Background:

• Hypertriglyceridaemia prevalence is increasing in Western populations, coinciding with rising rates of obesity and diabetes mellitus.
• Epidemiological data strongly suggest hypertriglyceridaemia is an independent risk factor for cardiovascular disease.
• Challenges exist in drug intervention studies due to triglyceride-lowering drugs also affecting high-density lipoprotein cholesterol levels.

Purpose of the Study:

• To review the current understanding of hypertriglyceridaemia.
• To discuss its causes, cardiovascular implications, and management strategies.

Main Methods:

• Literature review of epidemiological studies and clinical trials.
• Analysis of current guidelines for coronary risk management.
• Discussion of genetic and secondary causes of hypertriglyceridaemia.

Main Results:

• Despite epidemiological evidence, definitively proving hypertriglyceridaemia as a cardiovascular risk factor via drug trials is complex.
• Agreement on precise triglyceride target values remains challenging, though some guidelines now incorporate them.
• Both genetic and secondary causes contribute to hypertriglyceridaemia, necessitating thorough investigation before treatment.

Conclusions:

• Lifestyle modifications, including weight reduction, dietary changes, and exercise, are effective in managing hypertriglyceridaemia.
• Identifying and addressing underlying genetic or secondary causes is crucial for effective treatment.
• Further research may be needed to clarify the direct causal link and optimal therapeutic targets for hypertriglyceridaemia in cardiovascular disease prevention.